You are viewing a free limited preview of Abeome Corp.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

Abeome Corp.

Private Company Ticker Symbol™: (ABEOMEP)

Business Summary

Abeome Corp. is a privately-held, venture capital backed biotechnology company that focuses on research and development of monoclonal antibodies for clinical medicine and life sciences. Abeome Corp. is also involved in developing therapeutic diagnostic for ovarian cancer. Founded in 2000, Abeome Corp. is headquartered in Athens, Georgia.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:2000
Fiscal Year End:12/31
City:Athens
State/Province:Georgia
Country:United States
Phone:View
Website:www.abeomecorp.com

Industry Information

Industry Codes

PICS™:1500108
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology > Contract Biotechnology Research

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for Abeome Corp. displays the venture capital rounds, angel investments, debt or other funding raised by Abeome Corp..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Sep. 2008ViewOther
DetailsTotal Round Other View

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on Abeome Corp., you can see the following:

You are viewing a free limited preview of Abeome Corp.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access